Cannabis Industry & Legal Marijuana Opportunities Become Hot Topic for 2015 as Product Commercialization Programs Improve Cultivation Operations

CORAL SPRINGS, Florida, January 6, 2015 /PRNewswire/ --

As more and more medical marijuana dispensaries open in approved states, Cannabis/Marijuana Companies and Providers look for improved technology for innovative methods that address the energy and resources for intensive nature of indoor/outdoor cannabis cultivation. Companies in focus today are: Surna Inc. (OTC: SRNA), Cannabis Science, Inc. (OTC: CBIS), Nuvilex, Inc. (OTC: NVLX), GW Pharmaceuticals plc (NASDAQ: GWPH) and Easton Pharmaceuticals Inc. (OTC: EAPH) and Terra Tech Corp (OTC: TRTC).

Surna Inc. (OTCQB: SRNA), an engineering, manufacturing, and installation company specializing in commercial indoor cannabis cultivation technology, announced today it has appointed Bryon Jorgenson as Chief Operating Officer.  Jorgenson has more than 25 years of experience as an executive-level manager and engineer in the industrial electronics and industrial automation systems sectors.

Before joining Surna, Jorgenson was Chief Operations Officer and Founder of MIROPEX, LLC, a management consulting organization serving technology based companies; and has been focused on business development functions including product commercialization, pre-acquisition due diligence, business integration, management team transition, and operations performance improvement.  

"The vast experience Bryon possesses in leading new product commercialization programs will greatly enrich Surna's engineering proficiency and ability to consistently provide the most efficient, highest quality technology systems to the cannabis industry," said CEO Tom Bollich. "Bryon is an essential addition to the Surna team and will be pivotal to our success, permitting us more deftly develop and manufacture cutting-edge innovations in licensed cannabis cultivation."

Read the FULL SRNA Press Release at http://www.financialnewsmedia.com/profiles/srna.html

Surna, Inc. (http://www.surna.com) develops innovative technology and products that control or address the energy and resource intensive nature of indoor cannabis cultivation. Currently, the Company's revenue stream is based on its main product offerings - supplying industrial technology and products to commercial indoor cannabis grow facilities.  Headquartered in Boulder, CO, Surna's diverse engineering team is tasked with creating novel energy and resource efficient solutions, including the Company's signature water-cooled climate control platform. The Company's engineers continuously seek to create technology that solve the highly specific demands of the cannabis industry for temperature, humidity, light and process control.

In other developing Cannabis/Legal Marijuana News  & Happenings: Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, announced this week the International release of 8 initial products that will be synergistically produced, distributed and marketed across the Netherlands, Spain and California where Cannabis Science is active and has cannabis production facilities.  Read the full release at http://finance.yahoo.com/news/cannabis-science-inc-cbis-release-174300428.html

Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced in late December that the U.S. Food and Drug Administration (FDA) has granted Nuvilex orphan drug designation for its pancreatic cancer treatment. Nuvilex's pancreatic cancer treatment combines Nuvilex's patented and proprietary cellulose-based encapsulation technology, known as Cell-in-a-Box(R), with the cancer prodrug ifosfamide and encapsulated live cells that convert the prodrug into its cancer-killing form. These capsules are placed as close to the cancerous tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. This "targeted chemotherapy" has proven remarkably effective in past clinical trials.

GW Pharmaceuticals plc (NASDAQ: GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, recently announced that it has been selected for addition to the NASDAQ Biotechnology Index(R) (Nasdaq:NBI).  The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ listed securities that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NASDAQ Biotechnology Index is re-ranked semi-annually in May and November. The NASDAQ Biotechnology Index is the basis for the iShares Nasdaq Biotechnology Index(SM) Fund (IBB), which seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index. In addition, options based on the NASDAQ Biotechnology Index and the iShares NASDAQ Biotechnology Index Fund trade on various exchanges. For more information about the NASDAQ Biotechnology Index, including eligibility criteria, visit http://www.nasdaq.com.

Easton Pharmaceuticals Inc. (OTCPink: EAPH) announced on December 31st it has signed an agreement with Medicated Markets International LLC., a major California medical marijuana grower.  Easton Pharmaceuticals has been in search of and intent on entering the lucrative Medical Marijuana cultivation and distribution industry via the acquisition of a grower via a direct investment or through a partial reverse merger / acquisition. Easton Management is pleased to announce that both Medicated Markets and Easton Pharmaceuticals have reached an agreement in principle. Easton had intended to announce the progress made prior to the Christmas holidays on December 23rd but the holiday season and the California companies prior commitments made this date not attainable. Information withheld within this release shall be mentioned and highlighted in subsequent releases upon finalization of a final executed agreement has been which shall provide shareholders with a detailed outline of a final agreement reached with "Medicated Markets International LLC."

Terra Tech Corp  (OTCQB: TRTC) announced last month a new brand of exceptional quality cannabis products. IVXX, a wholly-owned subsidiary of Terra Tech, was developed by cannabis veterans Salwa Ibrahim and Derek Peterson, who believe in cannabis and its associated benefits. They and their entire IVXX team are committed to building a brand that delivers benchmark quality and consistency.   Read the full release at http://finance.yahoo.com/news/terra-tech-introduces-ivxx-tm-110700803.html

FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/.  Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter:  http://twitter.com/FNMgroup. 

DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand five hundred dollars for news coverage of the current press release issued by Surna, Inc. by the company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company: FN Media Group, LLC
Contact email: [email protected]
U.S. Phone: +1(954)345-0611
URL: http://www.financialnewsmedia.com

SOURCE FN Media Group LLC

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED